There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …

Magnetic field sensors are an integral part of many industrial and biomedical applications,
and their utilization continues to grow at a high rate. The development is driven both by new …

The emerging inverse electron demand Diels–Alder (IEDDA) reaction stands out from other
bioorthogonal reactions by virtue of its unmatchable kinetics, excellent orthogonality and …

The ability to isolate and analyze rare circulating tumor cells (CTCs) has the potential to
further our understanding of cancer metastasis and enhance the care of cancer patients. In …

Magnetic nanoparticles (MNPs) have attracted a growing interest in the development and
fabrication of sensors and biosensors for several applications. MNPs can be integrated into …

BACKGROUND The detection and molecular characterization of circulating tumor cells
(CTCs) are one of the most active areas of translational cancer research, with> 400 clinical …

Circulating tumor cells (CTCs) are shed into the bloodstream from primary and metastatic
tumor deposits. Their isolation and analysis hold great promise for the early detection of …

Rapid progress in identifying disease biomarkers has increased the importance of creating
high-performance detection technologies. Over the last decade, the design of many …

Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component
of cancer precision medicine ctDNAs. Compared to the traditional physical and biochemical …

Circulating tumor cells (CTC) released into blood from primary cancers and metastases
reflect the current status of tumor genotypes, which are prone to changes. Here, we …